Jennison Associates LLC Exact Sciences Corp Transaction History

Jennison Associates LLC

  • $141 Billion
  • Q1 2025

A detailed history of Jennison Associates LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Jennison Associates LLC holds 698,688 shares of EXAS stock, worth $36.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
698,688
Previous 762,736 8.4%
Holding current value
$36.7 Million
Previous $42.9 Million 29.43%
% of portfolio
0.02%
Previous 0.03%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 02, 2025
SELL
$43.04 - $58.51 $2.76 Million - $3.75 Million
-64,048 Reduced 8.4%
698,688 $30.2 Million
Q4 2024

Jan 24, 2025
SELL
$49.33 - $71.97 $6.01 Million - $8.77 Million
-121,923 Reduced 13.78%
762,736 $42.9 Million
Q3 2024

Nov 08, 2024
SELL
$42.43 - $70.83 $1.31 Million - $2.18 Million
-30,775 Reduced 3.36%
884,659 $60.2 Million
Q2 2024

Aug 05, 2024
BUY
$41.33 - $74.26 $11.6 Million - $20.9 Million
281,805 Added 44.47%
915,434 $38.7 Million
Q1 2024

May 02, 2024
SELL
$56.27 - $73.77 $40.9 Million - $53.7 Million
-727,288 Reduced 53.44%
633,629 $43.8 Million
Q4 2023

Feb 01, 2024
BUY
$59.06 - $75.72 $38.9 Million - $49.9 Million
659,235 Added 93.95%
1,360,917 $101 Million
Q3 2023

Oct 31, 2023
BUY
$65.94 - $99.04 $16.5 Million - $24.8 Million
250,501 Added 55.52%
701,682 $47.9 Million
Q2 2023

Aug 03, 2023
BUY
$62.68 - $95.05 $767,641 - $1.16 Million
12,247 Added 2.79%
451,181 $42.4 Million
Q1 2023

Apr 26, 2023
BUY
$47.19 - $70.77 $20.7 Million - $31.1 Million
438,934 New
438,934 $29.8 Million
Q4 2021

Feb 08, 2022
SELL
$72.5 - $100.68 $11.6 Million - $16.1 Million
-159,731 Closed
0 $0
Q3 2021

Nov 09, 2021
SELL
$90.24 - $124.05 $10.1 Million - $13.8 Million
-111,634 Reduced 41.14%
159,731 $15.2 Million
Q2 2021

Aug 12, 2021
BUY
$93.66 - $139.27 $4.61 Million - $6.86 Million
49,271 Added 22.18%
271,365 $33.7 Million
Q1 2021

May 11, 2021
BUY
$116.57 - $155.01 $25.9 Million - $34.4 Million
222,094 New
222,094 $29.3 Million
Q2 2020

Aug 06, 2020
SELL
$55.75 - $92.75 $80 Million - $133 Million
-1,435,861 Closed
0 $0
Q1 2020

May 06, 2020
SELL
$37.9 - $104.44 $159 Million - $438 Million
-4,191,138 Reduced 74.48%
1,435,861 $83.3 Million
Q4 2019

Feb 07, 2020
BUY
$77.66 - $99.74 $15.7 Million - $20.2 Million
202,478 Added 3.73%
5,626,999 $520 Million
Q3 2019

Nov 08, 2019
BUY
$90.37 - $122.49 $192 Million - $260 Million
2,120,591 Added 64.18%
5,424,521 $490 Million
Q2 2019

Aug 06, 2019
BUY
$89.51 - $118.04 $202 Million - $267 Million
2,261,394 Added 216.91%
3,303,930 $0
Q1 2019

May 10, 2019
SELL
$61.98 - $96.5 $131,025 - $204,001
-2,114 Reduced 0.2%
1,042,536 $90.3 Million
Q4 2018

Feb 06, 2019
SELL
$56.04 - $82.66 $6.07 Million - $8.96 Million
-108,336 Reduced 9.4%
1,044,650 $65.9 Million
Q3 2018

Nov 08, 2018
BUY
$48.29 - $80.6 $9.02 Million - $15.1 Million
186,726 Added 19.32%
1,152,986 $91 Million
Q2 2018

Aug 02, 2018
BUY
$37.84 - $69.96 $154,992 - $286,556
4,096 Added 0.43%
966,260 $57.8 Million
Q1 2018

Apr 20, 2018
BUY
$39.82 - $57.53 $17.7 Million - $25.5 Million
443,575 Added 85.53%
962,164 $38.8 Million
Q4 2017

Jan 25, 2018
BUY
$46.49 - $60.51 $17.4 Million - $22.6 Million
374,078 Added 258.86%
518,589 $27.2 Million
Q3 2017

Nov 03, 2017
BUY
$37.05 - $47.12 $5.35 Million - $6.81 Million
144,511
144,511 $6.81 Million

Others Institutions Holding EXAS

# of Institutions
647
Shares Held
157M
Call Options Held
1.74M
Put Options Held
1.56M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.29B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email